Diabetes and Glaucoma: Understanding the Connection
How Diabetes Increases Your Risk of Glaucoma
If you have diabetes, protecting your vision means staying alert to more than just retinopathy. According to a 2024 study published in JAMA Ophthalmology, approximately 4.22 million U.S. adults have glaucoma, and research shows that people with diabetes may face up to a 40 percent higher risk of developing open-angle glaucoma (JAMA Ophthalmology, 2024). At Greenwich Ophthalmology Associates, serving the greater NY/CT region, our diabetic eye care specialist and glaucoma specialists work together to monitor and manage both conditions in patients with diabetes. Understanding the link between these two diseases is a critical step toward preserving your long-term eye health.
Chronically elevated blood sugar levels can damage the small blood vessels that supply the trabecular meshwork, the eye's primary drainage channel. When this drainage system becomes less efficient, fluid builds up inside the eye, raising intraocular pressure (IOP). Elevated IOP is the most significant modifiable risk factor for glaucoma, and people with diabetes are roughly twice as likely to develop open-angle glaucoma compared to those without the disease.
Open-angle glaucoma is the most common form and also the type most closely linked to diabetes. In this condition, the drainage angle of the eye remains open but functions poorly, allowing pressure to build gradually. Because this pressure increase is painless and the peripheral vision loss it causes is subtle at first, many patients do not notice symptoms until significant damage has occurred. You can learn more about how diabetes affects various structures of the eye and why early detection matters.
Advanced diabetic eye disease can trigger the growth of abnormal new blood vessels on the iris and over the drainage angle, a process called neovascularization. These fragile vessels can block the outflow of aqueous humor and cause a rapid, severe rise in eye pressure. Diabetes also promotes chronic low-grade inflammation throughout the body, including the eye. This inflammatory state can alter the composition of the trabecular meshwork and reduce its ability to drain fluid effectively.
What Is Neovascular Glaucoma
Neovascular glaucoma (NVG) is one of the most serious eye complications associated with diabetes and represents a direct consequence of advanced retinal disease. When diabetic retinopathy progresses to its proliferative stage, the retina becomes starved of oxygen. In response, the eye releases vascular endothelial growth factor (VEGF), a chemical signal that stimulates the growth of new blood vessels. Unfortunately, these new vessels are structurally abnormal and fragile. When they grow across the iris and into the drainage angle of the eye, they form a membrane that physically obstructs the outflow of aqueous humor.
Unlike the slow onset of open-angle glaucoma, neovascular glaucoma often presents with noticeable symptoms. Patients may experience sudden eye pain, redness, blurred or declining vision, and visible blood vessels on the surface of the iris. Some patients also report nausea or headache from the acutely elevated pressure. These symptoms require urgent evaluation because the window for effective treatment is limited.
Managing neovascular glaucoma typically involves a combination of therapies. Anti-VEGF injections are often the first step, administered directly into the eye to halt the growth of abnormal blood vessels and allow the drainage angle to begin reopening. Panretinal photocoagulation (PRP) laser treatment may follow to reduce the oxygen demand of the damaged retina and prevent further neovascularization. If pressure remains elevated despite these measures, our glaucoma specialists may recommend surgical options such as drainage implant devices to lower IOP and protect the optic nerve.
Symptoms of Glaucoma in Diabetic Patients
Recognizing glaucoma symptoms early can be challenging, especially for patients already managing the visual effects of diabetes. Open-angle glaucoma, the type most common in diabetic patients, typically causes no pain and no noticeable change in central vision until the disease has progressed significantly. Peripheral (side) vision is lost gradually, and most patients compensate unconsciously by turning their head or eyes. This is why glaucoma is sometimes called 'the silent thief of sight.' For patients with diabetes, overlapping symptoms from diabetic retinopathy or macular edema can further mask early glaucoma changes.
As glaucoma advances, you may begin to notice certain changes in your vision. These can include gradual loss of peripheral vision often in both eyes, difficulty adjusting to low-light environments, trouble seeing objects off to the side while looking straight ahead, and tunnel-like vision in later stages.
If you experience sudden eye pain, a sharp headache centered around one eye, nausea, halos around lights, or an abrupt decrease in vision, seek care right away. These symptoms can indicate an acute pressure spike such as angle-closure glaucoma or neovascular glaucoma, both of which require prompt treatment to prevent permanent optic nerve damage.
How Glaucoma Screening Differs for Diabetic Patients
Standard eye exams already include basic glaucoma checks, but patients with diabetes benefit from a more thorough and frequent evaluation protocol. During a diabetic eye exam, our specialists perform a dilated fundus examination to inspect the retina, optic nerve, and blood vessels in detail. For glaucoma screening, additional tests are layered in. These typically include tonometry to measure intraocular pressure, optical coherence tomography (OCT) to assess the thickness of the retinal nerve fiber layer around the optic nerve, and visual field testing to map any areas of peripheral vision loss.
The American Academy of Ophthalmology recommends that adults with Type 2 diabetes have a comprehensive dilated eye exam at the time of diagnosis and annually thereafter. Those with Type 1 diabetes should begin screening within five years of diagnosis. If any signs of glaucoma or elevated eye pressure are detected, your monitoring schedule may increase to every three to six months. Patients with proliferative diabetic retinopathy are monitored even more closely because of the heightened risk of neovascular glaucoma.
Because diabetes can affect both the retina and the optic nerve, our diabetic eye care specialist and glaucoma specialists often coordinate their evaluations. This means your diabetic retinal screening and glaucoma monitoring can be addressed in a streamlined visit, reducing the need for multiple appointments while ensuring that no aspect of your eye health is overlooked.
Frequently Asked Questions
Some diabetes medications, particularly corticosteroids used to manage diabetic macular edema, can raise intraocular pressure as a side effect. Steroid-induced pressure elevation is well documented and typically reversible once the medication is reduced or discontinued. If you require steroid treatment for diabetic eye disease, our team will monitor your eye pressure closely throughout the course of therapy. Standard blood sugar medications such as metformin and insulin do not directly raise eye pressure.
Treatment follows the same stepwise approach used for all glaucoma patients, beginning with pressure-lowering eye drops and advancing to laser procedures or surgery when needed. However, the treatment plan for diabetic patients may also include anti-VEGF injections or retinal laser therapy if diabetic retinopathy is contributing to elevated pressure. Our specialists tailor the approach based on the type and severity of glaucoma, the status of the retina, and your overall health.
Keeping blood sugar, blood pressure, and cholesterol within target ranges reduces damage to the small blood vessels throughout the eye. Good metabolic control slows the progression of diabetic retinopathy, which in turn lowers the risk of developing neovascular glaucoma. Studies also suggest that stable blood sugar levels help maintain healthier drainage function within the eye.
Yes. Proliferative diabetic retinopathy, the most advanced stage of the disease, can directly cause neovascular glaucoma through the growth of abnormal blood vessels that block the eye's drainage system. Even non-proliferative retinopathy can contribute to subtle changes in the trabecular meshwork. This is one reason why regular monitoring of diabetic retinopathy stages is so important.
Most patients with diabetes should have a comprehensive dilated eye exam at least once a year. If you have been identified as a glaucoma suspect or have elevated eye pressure, visits every three to six months are typical. Patients with active proliferative retinopathy or those who have already been diagnosed with glaucoma may need to be seen even more frequently. Your monitoring schedule will be personalized based on your individual risk factors.
What our Patients say
4.8
Reviews
(3645)